论文部分内容阅读
重症病毒性肝炎(简称重肝)病死率极高.为了全面、客现评价重肝各种疗法的效果.自1991年1月来.我们对191例重肝随机分组治疗.进行疗效对比观察,现报道如下。 资料和方法 病毒性肝炎诊断际准和疗效评价参照上海第六届全国病毒性肝炎学术会议修订标准.经肝穿病理证实46例。191例中出现Ⅱ度或Ⅱ度以上肝昏迷66例,大量腹水114例,继发感染112例,肝肾综合征33例,上消化道大出血68例。血清病原学检查证实乙型肝炎169例(其中重叠甲型肝炎7例.重叠丙型肝炎4例),丙型肝炎2例。
Severe viral hepatitis (referred to as the liver) mortality is extremely high.In order to comprehensively, the current evaluation of the effect of various liver therapy.From January 1991. We were 191 cases of severe liver randomized treatment.Comparison of efficacy, Report as follows now. Materials and Methods The diagnostic criteria and therapeutic evaluation of viral hepatitis were based on the revised standards of the Sixth National Symposium on Viral Hepatitis in Shanghai. In 191 cases, there were 66 cases of hepatic coma Ⅱ degree or more, 114 cases of large amount of ascites, 112 cases of secondary infection, 33 cases of hepatorenal syndrome and 68 cases of upper gastrointestinal bleeding. Serum etiological examination confirmed 169 cases of hepatitis B (including 7 cases of hepatitis A overlap, 4 cases of overlapping hepatitis C), hepatitis C in 2 cases.